NO20050658L - Fremgangsmater for behandling av erektil dysfunksjon i menn - Google Patents

Fremgangsmater for behandling av erektil dysfunksjon i menn

Info

Publication number
NO20050658L
NO20050658L NO20050658A NO20050658A NO20050658L NO 20050658 L NO20050658 L NO 20050658L NO 20050658 A NO20050658 A NO 20050658A NO 20050658 A NO20050658 A NO 20050658A NO 20050658 L NO20050658 L NO 20050658L
Authority
NO
Norway
Prior art keywords
methods
erectile dysfunction
men
treatment
patient
Prior art date
Application number
NO20050658A
Other languages
English (en)
Norwegian (no)
Inventor
James L Yeager
Nadir Bueyuektimkin
Servet Bueyuektimkin
Original Assignee
Nexmed Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/236,485 external-priority patent/US7105571B2/en
Application filed by Nexmed Holdings Inc filed Critical Nexmed Holdings Inc
Publication of NO20050658L publication Critical patent/NO20050658L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20050658A 2002-09-06 2005-02-08 Fremgangsmater for behandling av erektil dysfunksjon i menn NO20050658L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/236,485 US7105571B2 (en) 2000-01-10 2002-09-06 Prostaglandin compositions and methods of treatment for male erectile dysfunction
US48327803P 2003-06-27 2003-06-27
PCT/US2003/027885 WO2004022064A1 (fr) 2002-09-06 2003-09-05 Procedes de traitement des troubles de l'erection chez l'homme

Publications (1)

Publication Number Publication Date
NO20050658L true NO20050658L (no) 2005-04-01

Family

ID=31980977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050658A NO20050658L (no) 2002-09-06 2005-02-08 Fremgangsmater for behandling av erektil dysfunksjon i menn

Country Status (10)

Country Link
EP (1) EP1534297A1 (fr)
JP (1) JP2006512291A (fr)
KR (1) KR20050057245A (fr)
CN (1) CN1674912A (fr)
AU (1) AU2003273291A1 (fr)
CA (1) CA2493723A1 (fr)
EA (1) EA200500452A1 (fr)
IL (1) IL166273A0 (fr)
NO (1) NO20050658L (fr)
WO (1) WO2004022064A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050181030A1 (en) * 2003-01-03 2005-08-18 Mo Y. J. Topical stabilized prostaglandin E compound dosage forms
JP2006520788A (ja) * 2003-03-21 2006-09-14 ネックスメド ホールディングス インコーポレイテッド プロスタグランジン組成物による血管形成促進および方法
MXPA05010069A (es) * 2003-03-21 2005-11-23 Nexmed Holdings Inc Composiciones de prostaglandina para el tratamiento de la disfuncion erectil.
EP3266458A1 (fr) 2016-07-05 2018-01-10 Fagron B.V. Procédé et composition et kit pour traiter un dysfonctionnement érectile

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323241B1 (en) * 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction
WO2003070281A1 (fr) * 2002-02-15 2003-08-28 Nexmed (Holdings), Inc. Composition de prostaglandine pour le traitement des troubles de l'erection

Also Published As

Publication number Publication date
CN1674912A (zh) 2005-09-28
JP2006512291A (ja) 2006-04-13
EP1534297A1 (fr) 2005-06-01
EA200500452A1 (ru) 2005-10-27
AU2003273291A1 (en) 2004-03-29
CA2493723A1 (fr) 2004-03-18
WO2004022064A1 (fr) 2004-03-18
IL166273A0 (en) 2006-01-15
KR20050057245A (ko) 2005-06-16

Similar Documents

Publication Publication Date Title
MY151032A (en) Treatment of tnf? related disorders
GB2432939A (en) A frequency and voltage scaling architecture
NO20055415L (no) Humaniserte antistoffer som gjenkjenner beta-amyloidpeptid
BRPI0506970B8 (pt) derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior
WO2007087468A3 (fr) L'adiponectine pour le traitement de divers troubles
MA32539B1 (fr) Traitement du diabète chez des patients pour lesquels une thérapie par la metformine n'est pas appropriée
WO2004014352A3 (fr) Methodes de traitement de troubles dont la mediation est assuree par l'anhydrase carbonique
WO2005013950A3 (fr) Inhibition pharmacologique selective du trafic proteique et methodes associees de traitement de maladies humaines
NO20091296L (no) Fremgangsmate for behandling av slag med trombolytisk middel
NO20092612L (no) Forbindelser og metode for kinasemodulering og indikasjoner for dette
NO20054371L (no) Somatostatin-dopamin kimaere analoger
NO20063300L (no) Fremgangsmater for behandling av akutt inflammasjon i dyr med p38 MAP kinaseinhibitorer
WO2002036123A3 (fr) Nouveaux traitements destines au syndrome des jambes sans repos
WO2005044199A3 (fr) Combinaison d'un inhibiteur de pompe a protons et d'un agent favorisant le sommeil
BRPI0507086A (pt) método para tratar sintomas de depressão, método monoterapêutico para tratar um paciente quanto aos sintomas de depressão, e, uso de um composto de quetiapina ou um seu sal farmaceuticamente aceitável
TW200505829A (en) Protease inhibitors for coronaviruses and sars-cov and the use thereof
WO2007038506A3 (fr) Methode de traitement de la cachexie
NO20050658L (no) Fremgangsmater for behandling av erektil dysfunksjon i menn
WO2006133374A3 (fr) Methodes de traitement du choc
DK1228708T4 (da) Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk
WO2007023310A3 (fr) Stimulation de la neurogenese
ATE399557T1 (de) Selektive norepinephrin-wiederaufnahmehemmer zur behandlung von hitzewallungen
RS20050774A (en) Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques
WO2002056876A3 (fr) Traitement pour le ronflement
WO2003080665A3 (fr) Traitement de l'infection par l'encephalopathie spongiforme transmissible